HOOKIPA Pharma (HOOK)

• Market cap: $22.3M
• 1 day: -2.63%
• 5 days: -7.50%
• 1 month: -20.26%
• 3 months: -55.85%
• 6 months: -71.09%
• Year to date: -77.71%
• 1 year: -76.88%
• 5 years: -98.48%
• 10 years: -98.68%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Employees: 124

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0.32% more ownership

Funds ownership: 36.75% [Q2] → 37.07% (+0.32%) [Q3]

4% less capital invested

Capital invested by funds: $21M [Q2] → $20.2M (-$777K) [Q3]

15% less funds holding

Funds holding: 41 [Q2] → 35 (-6) [Q3]

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

82% less call options, than puts

Call options by funds: $155K | Put options by funds: $868K

91% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 23

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $2 8% upside
• Avg. target: $4.50 143% upside
• High target: $7 278% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

RBC Capital Brian Abrahams 15% 1-year accuracy 12 / 79 met price target	8% upside $2	Sector Perform Downgraded	20 Dec 2024
JMP Securities Roy Buchanan 19% 1-year accuracy 3 / 16 met price target	278% upside $7	Market Outperform Maintained	21 Nov 2024